Intrinsiqs

Is Denali Therapeutics Inc. overvalued?

Denali Therapeutics Inc. (DNLI) — key valuation metrics and fundamentals.

No verdict
Price
$25.61
Fair value
Current P/E
Normal P/E
Market cap
$4.11B
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares DNLI's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 29 Jun 2026.